Other drugs on the market such as Mounjaro (tirzepatide), which was approved for treating Type 2 diabetes but also seems to help with weight loss, could also see greater interest
Additionally, sustained engagement in physical activity after treatment cessation appears more likely when exercise is integrated alongside pharmacotherapy, while GLP-1 therapies alone may be associated with lower post-treatment activity levels
GLP-1 medications such as Wegovy, Ozempic, and Zepbound have become increasingly popular for treating obesity and Type 2 diabetes, but insurance coverage for these medications remains inconsistent and financially challenging for consumers who have resorted to getting their GLP1s through other avenues
The The federal health agency also suggests at least 2 days a week of strength training
FDAs Concers With Unapproved GLLP-1 Drugs Used for Weight Loss
Active ingredient: The active ingredient in Trulicity is dulaglutide which is 90% similar to human GLP-1
